Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 5:381:1179.
doi: 10.1136/bmj.p1179.

Male sling is as good as more complex surgery for incontinence after prostate surgery

Helen Saul  1 , Brendan Deeney  1 , Samantha Cassidy  1 , Jemma Kwint  1 , Lynda Constable  2 , Paul Abrams  3
Affiliations

Male sling is as good as more complex surgery for incontinence after prostate surgery

Helen Saul et al. BMJ. .

Abstract

The studyConstable L, Abrams P, Cooper D, et. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT. Health Technol Assess 2022;26:1-152To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/male-sling-is-as-good-as-more-complex-surgery-for-incontinence-after-prostate-surgery/.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Paul Abrams reports consultancies with Astellas Pharma Inc (Tokyo, Japan), Ipsen (Paris, France) and Recordati (Milan, Italy); reports being a lecturer for Astellas Pharma Inc, Pfizer Inc (New York, NY, USA), Cipla (Mumbai, India), Ferring Pharmaceuticals (Saintt-Prex, Switzerland) and Sun Pharma (Mumbai, India); and is a triallist for Astellas Pharma Inc, outside the submitted work. Chris Harding reports personal fees from Astellas Pharma Inc, Medtronic (Dublin, Ireland) and Allergan (Dublin, Ireland); grants from Medtronic; personal fees from Teleflex Medical (Wayne, PA, USA) and GlaxoSmithKline (Brentford, UK); and research grants from the National Institute for Health and Care Research (NIHR) and The Urology Foundation (London, UK) outside the submitted work. Marcus J Drake reports personal fees from Astellas Pharma Inc and Pfizer Inc, outside the submitted work and is a trustee of the International Continence Society (Bristol, UK). Nikki Cotterill reports grants from NIHR during the conduct of the study. Craig Ramsay reports membership of the NIHR Health Technology Assessment (HTA) General Board (2017-present). John Norrie reports grants from the University of Aberdeen (Aberdeen, UK) and the University of Edinburgh (Edinburgh, UK) during the conduct of the study and declares membership of the following NIHR/Medical Research Council boards: Efficacy and Mechanism Evaluation (EME) Funding Board (chairperson, 2019-present), Cardiopulmonary Resuscitation Decision-making Committee (2016), HTA Commissioning Board (2010-16), HTA Commissioning Sub-Board (Expression of Interest) 2012-16, HTA Funding Boards Policy Group (2016), HTA General Board (2016-19), HTA Post-Board Funding Teleconference (2016-19), NIHR Clinical Trials Unit Standing Advisory Committee (2017-present), NIHR HTA and EME Editorial Board (2014-19) and Pre-exposure Prophylaxis Impact Review Panel (2017-present). All authors contributed to the development and review of this summary, as part of the wider NIHR Alerts editorial team.

LinkOut - more resources